---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-011954"
form_type: "8-K"
ticker: null
cik: "0001792581"
company_name: "Kiromic Biopharma, Inc."
filed_at: "2023-07-18T23:59:59+00:00"
generated_at: "2026-06-13T07:10:46.889489+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Kiromic BioPharma amends bylaws to set stockholder meeting quorum at one-third of outstanding shares

## Summary
- Quorum reduced to 33.33% of issued and outstanding shares entitled to vote.
- Amendment approved by Board on July 17, 2023 and effective immediately.
- Change intended to improve the Company's ability to hold stockholder meetings.
- No other changes to Bylaws were made.

## SEC filing metadata
- accession: 0001558370-23-011954
- form_type: 8-K
- cik: 0001792581
- company_name: Kiromic Biopharma, Inc.
- filed_at: 2023-07-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1792581/000155837023011954/0001558370-23-011954-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1792581/000155837023011954/krbp-20230717x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-011954
- JSON: https://secwatch.observer/filing/0001558370-23-011954.json
- Plain text: https://secwatch.observer/filing/0001558370-23-011954.txt

## Key facts
- Governance Changes
  Kiromic Biopharma, Inc.: Amended bylaws to reduce quorum for stockholder meetings to one-third of shares outstanding (effective 2023-07-17).
  - Change: bylaw amendment
  - Effective: 2023-07-17
  source text: On July 17, 2023, the Board of Directors of Kiromic BioPharma, Inc. (the “Company”) approved an amendment of the Company’s Bylaws (the “Bylaws”) to change the quorum for stockholder meetings to equal one-third (33.33%) of the shares issued and outstanding and entitled to vote on the matters at the meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792581/000155837023011954/0001558370-23-011954-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.